MACH7 TECHNOLOGIES LIMITED — Capital/Financing Update 2022

Dec 19, 2022

ASX Announcement

==> picture [105 x 26] intentionally omitted <==

20 December 2022

NUVODIA SALES ORDER SOLIDIFIES MACH7 PARTNERSHIP

• ¨ Subscription licence agreement with Nuvodia; Total Contract Value of ~$2.5 million[1]

• ¨ Licence agreement for full Mach7 product suite; volume to grow with Nuvodia customer base

• ¨ Nuvodia partnership gives Mach7 an additional pathway to the high growth outpatient market

Mach7 Technologies Limited (“Mach7” or the “Company”) (ASX:M7T), a company specialising in innovative medical imaging software solutions, is pleased to announce its inaugural sales order from new partner, Nuvodia.

The agreement with Nuvodia involves Mach7’s entire Enterprise Imaging Platform including its Vendor Neutral Archive (VNA), eUnity Diagnostic Viewer and Workflow applications to provide a true enterprise wide PACS solution for healthcare providers. The subscription contract has a five-year term and a Total Contract Value (TCV) of $2.5 million.

Headquartered in Spokane Washington, Nuvodia is a national IT and radiology service provider that creates, manages, and supports mission-critical IT environments. Nuvodia has a long history of providing enterprise-class technology solutions to independent radiology practices, outpatient imaging centres and community hospitals.

Under this agreement, Nuvodia will expand its products and services by offering Mach7’s innovative Enterprise Imaging Solution to its customers. Nuvodia selected Mach7 as a partner for its ability to deploy a truly vendor agnostic platform to capture, store, and publish medical imaging data. The implementation of Mach7’s interoperable, advanced product suite allows healthcare providers to image-enable the Electronic Medical Record (EMR), create distributed use and adoption of AI algorithms, connect to the latest cloud technologies, provide clinical workflow optimisation and utilise insightful business intelligence analytics.

Also, important to the selection criteria was Mach7’s IT-friendly, zero footprint diagnostic viewer which, can be used by healthcare professionals inside or outside the walls of healthcare facilities to provide primary or secondary diagnostic readings.

CEO and Managing Director of Mach7, Mike Lampron said: “ The strength of this new partnership is evidenced by the $2.5 million five-year commitment Nuvodia made within months of formalising the relationship. The licence agreement allows Nuvodia to install Mach7’s software in its cloud infrastructure enabling the resale and deployment of our products to Nuvodia’s existing and new customers, creating ongoing sales and service opportunities for Mach7. Independent research highlights the accelerating trend toward outpatient imaging centres and our partnership with Nuvodia broadens our reach to this market segment .”

1 Exchange rate: AUD/USD = $0.65

Released on authority of the Board by:

Mike Lampron Chief Executive Officer

For more information, contact:

Investor Relations:

Rebecca Thompson +61 (0) 416 079 329 rebecca.thompson@mach7t.com

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T) is a medical imaging systems provider that develops innovative image management and viewing solutions for healthcare organisations. The core of these offerings is the Mach7 Enterprise Imaging Solution, encompassing Enterprise Data Management, Enterprise Diagnostic Viewing and Diagnostic Workflow applications. Mach7’s Enterprise Data Management solution, consisting of a powerful Vendor Neutral Archive (VNA) and data administration tools, allows for the fast storage, access, retrieval and viewing of images across a healthcare network with connectivity to the Cloud. In July 2020, Mach7 acquired Client Outlook and the eUnity Enterprise Diagnostic Viewing technology to augment Mach7’s Enterprise Data Management and Diagnostic Workflow applications. eUnity is a zero-footprint, FDA-approved, image viewing solution that makes images accessible on any workstation. This offers healthcare professionals consolidated access to all patient images and data, ensuring clinical staff have timely access to the right information to diagnose and treat patients. Uniquely, the company also gives customers independence to deploy its solutions either on a component basis or in a unified comprehensive platform. Mach7 has built a global network of diverse customers that range from expansive Integrated Delivery Networks, National Health Systems, medical research facilities, and large academic medical institutions to regional community hospitals, private radiology practices, and independent provider groups. Visit Mach7t.com.

==> picture [150 x 53] intentionally omitted <==

Mach7 Technologies Limited (ASX:M7T) ABN: 26 007 817 192 Registered Office: Level 4, 96 – 100 Albert Road, South Melbourne, VIC 3205 T: 03 9692 7222 www.mach7t.com